Previous studies have also indicated abnormal expression of E-cadherin in gastric cancer tissues, closely correlated with clinical characteristics such as Lauren classification, depth of infiltration, degree of differentiation, lymph node metastasis, and TNM staging (8, 9). This evidence concerns the gene CDH1 and gastric cancer.